Tag: pharmaceutical competition
180-Day Exclusivity and Authorized Generics: Legal Pitfalls and Market Impact
The 180-day exclusivity rule was meant to reward generic drug makers for challenging patents-but authorized generics let brand-name companies undercut them. Here’s how the law works, why it’s failing, and what’s being done to fix it.
Patent Litigation: How Authorized Generics Undermine Generic Drug Competition
Authorized generics let brand-name drug makers launch their own cheap versions during the first generic’s exclusivity period, crushing real competition and keeping prices high. Here’s how it works-and why it’s hurting patients.